However, some discrepancies have been suggested regarding its implications in PGRN expression, where the rs5848 variant translated in the decrease of GRN mRNA levels in the parietal lobe and PBMCs of AD patients [10] but also has been described to no altered GRN expression in serum levels between controls and AD patients [167]. This evidence concerns the gene GRN and Alzheimer disease.